ANGLE plc (LON:AGL,OTCQX:ANPCY) founder and chief executive Andrew Newland tells Proactive their ground-breaking liquid biopsy has outperformed current tests used to tell whether a pelvic mass is malignant or benign.
ANGLE PLC boss 'absolutely delighted' with results from pelvic mass study
Quick facts: ANGLE PLC
Price: 40.49 GBX
Market Cap: £87.22 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ANGLE PLC named herein, including the promotion by the Company of ANGLE PLC in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE